ACADIA Pharmaceuticals, Inc. (ACAD)
27.83
+0.09
(+0.32%)
USD |
NASDAQ |
Sep 11, 16:00
27.84
0.00 (0.00%)
After-Hours: 20:00
ACADIA Pharmaceuticals Price : 27.83 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 27.98 | 28.24 | 27.74 | 27.83 | 1.173M |
| Sep 10, 2026 | 27.63 | 27.86 | 27.36 | 27.74 | 1.015M |
| Sep 09, 2026 | 27.44 | 27.95 | 27.40 | 27.68 | 1.294M |
| Sep 08, 2026 | 27.63 | 28.09 | 27.10 | 27.58 | 1.458M |
| Sep 04, 2026 | 27.77 | 28.19 | 27.65 | 28.02 | 1.683M |
| Sep 03, 2026 | 29.00 | 29.06 | 27.62 | 27.86 | 1.849M |
| Sep 02, 2026 | 29.10 | 29.75 | 28.88 | 28.93 | 1.556M |
| Sep 01, 2026 | 28.84 | 29.30 | 28.51 | 28.89 | 830929.0 |
| Aug 31, 2026 | 29.05 | 29.12 | 28.58 | 28.91 | 1.036M |
| Aug 28, 2026 | 29.51 | 29.72 | 29.02 | 29.11 | 1.530M |
| Aug 27, 2026 | 29.26 | 29.83 | 29.15 | 29.73 | 879366.0 |
| Aug 26, 2026 | 30.36 | 30.38 | 29.28 | 29.58 | 1.336M |
| Aug 25, 2026 | 30.14 | 30.76 | 29.84 | 30.57 | 1.524M |
| Aug 24, 2026 | 29.50 | 29.78 | 29.15 | 29.65 | 1.490M |
| Aug 21, 2026 | 29.08 | 29.62 | 28.80 | 29.50 | 1.094M |
| Aug 20, 2026 | 30.00 | 30.00 | 28.95 | 29.04 | 1.319M |
| Aug 19, 2026 | 30.66 | 30.96 | 30.07 | 30.21 | 2.288M |
| Aug 18, 2026 | 29.14 | 30.25 | 29.05 | 30.18 | 2.054M |
| Aug 17, 2026 | 28.63 | 29.03 | 28.21 | 29.01 | 1.122M |
| Aug 14, 2026 | 28.26 | 28.42 | 27.90 | 28.24 | 1.063M |
| Aug 13, 2026 | 29.75 | 29.75 | 28.36 | 28.38 | 1.507M |
| Aug 12, 2026 | 29.18 | 29.85 | 28.83 | 29.45 | 1.410M |
| Aug 11, 2026 | 29.56 | 29.76 | 29.10 | 29.41 | 1.347M |
| Aug 10, 2026 | 29.00 | 29.65 | 29.00 | 29.39 | 2.726M |
| Aug 07, 2026 | 28.57 | 29.29 | 28.20 | 29.21 | 1.783M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Incyte Corp. | 121.47 |
| Agios Pharmaceuticals, Inc. | 33.60 |
| Biogen, Inc. | 217.15 |
| Insmed, Inc. | 129.41 |
| Arcutis Biotherapeutics, Inc. | 23.88 |
Price Related Metrics
| PE Ratio | 12.53 |
| PS Ratio | 4.201 |
| PEG Ratio | 0.1875 |
| Price to Book Value | 3.666 |
| Price to Free Cash Flow | 32.85 |
| Earnings Yield | 7.98% |
| Market Cap | 4.790B |
| PEGY Ratio | 0.1875 |
| Operating PE Ratio | 55.39 |
| Normalized PE Ratio | 12.53 |